Evidence map›Paper›PMID 35975008›Full record

ArticleRSC chemical biology2022

Mutant polymerases capable of 2' fluoro-modified nucleic acid synthesis and amplification with improved accuracy.

Trevor A Christensen, Kristi Y Lee, Simone Z P Gottlieb, Mikayla B Carrier, Aaron M Leconte

Abstract read
In one paragraph

Article in RSC chemical biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Trevor A ChristensenW. M. Keck Science Department of Claremont McKenna, Pitzer, and Scripps Colleges Claremont CA USA aleconte@kecksci.claremont.edu.
Kristi Y LeeW. M. Keck Science Department of Claremont McKenna, Pitzer, and Scripps Colleges Claremont CA USA aleconte@kecksci.claremont.edu.
Simone Z P GottliebW. M. Keck Science Department of Claremont McKenna, Pitzer, and Scripps Colleges Claremont CA USA aleconte@kecksci.claremont.edu.
Mikayla B CarrierW. M. Keck Science Department of Claremont McKenna, Pitzer, and Scripps Colleges Claremont CA USA aleconte@kecksci.claremont.edu.
Aaron M LeconteW. M. Keck Science Department of Claremont McKenna, Pitzer, and Scripps Colleges Claremont CA USA aleconte@kecksci.claremont.edu.ORCID https://orcid.org/0000-0002-5789-9147

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nonnatural nucleic acids (xeno nucleic acids, XNA) can possess several useful properties such as expanded reactivity and nuclease resistance, which can enhance the utility of DNA as a biotechnological tool. Native DNA polymerases are unable to synthesize XNA, so, in recent years mutant XNA polymerases have been engineered with sufficient activity for use in processes such as PCR. While substantial improvements have been made, accuracy still needs to be increased by orders of magnitude to approach natural error rates and make XNA polymerases useful for applications that require high fidelity. Here, we systematically evaluate leading Taq DNA polymerase mutants for their fidelity during synthesis of 2'F XNA. To further improve their accuracy, we add mutations that have been shown to increase the fidelity of wild-type Taq polymerases, to some of the best current XNA polymerases (SFM4-3, SFM4-6, and SFP1). The resulting polymerases show significant improvements in synthesis accuracy. In addition to generating more accurate XNA polymerases, this study also informs future polymerase engineering efforts by demonstrating that mutations that improve the accuracy of DNA synthesis may also have utility in improving the accuracy of XNA synthesis.

Identifiers

PMID35975008
PMCPMC9347352

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.